Why Early-Stage symptoms are sometimes dismissed

# Article sur les symptômes précoces parfois négligés

Every year, thousands of patients experience the frustration of having their early-stage symptoms overlooked, minimised, or attributed to less serious conditions. This phenomenon affects people across all demographics, but research shows that women, minority populations, and those with pre-existing mental health conditions face disproportionately high rates of symptom dismissal. The consequences can be severe: delayed diagnoses, progression of treatable conditions, and a breakdown of trust between patients and healthcare professionals. Understanding why this happens requires examining the complex interplay of cognitive biases, systemic pressures, communication barriers, and demographic factors that influence how symptoms are assessed and validated in clinical settings.

The problem extends beyond individual doctor-patient interactions. Studies indicate that approximately one in four people who visit a GP present with physical symptoms that cannot be immediately explained, yet many of these individuals go on to receive diagnoses for serious conditions months or years later. Recent research published in the British Medical Journal has shown improvements in cancer survival rates when conditions are caught early, yet diagnostic delays remain alarmingly common. The challenge lies not just in medical knowledge gaps, but in the systematic ways that early-stage symptoms can be misinterpreted, overlooked, or wrongly attributed to psychological factors.

Cognitive biases in clinical symptom assessment

Medical decision-making, despite its scientific foundation, remains vulnerable to the same cognitive shortcuts that affect all human judgement. These mental processes, known as heuristics, help clinicians process vast amounts of information quickly, but they can also lead to systematic errors in symptom assessment. Understanding these biases is essential for improving diagnostic accuracy and reducing the dismissal of legitimate early-stage symptoms.

Anchoring bias and initial patient presentation

Anchoring bias occurs when a clinician fixates on the first piece of information presented during a consultation, allowing it to disproportionately influence subsequent diagnostic reasoning. If a patient begins by mentioning stress or anxiety, or if their medical records prominently feature a mental health diagnosis, this initial “anchor” can colour the entire assessment. Research shows that once an anchor is established, clinicians often seek information that confirms this initial impression rather than exploring alternative explanations. This phenomenon is particularly problematic for early-stage symptoms that present vaguely or overlap with stress-related complaints. A patient reporting fatigue and difficulty concentrating might be anchored to an anxiety diagnosis, when these could equally represent early thyroid dysfunction or autoimmune disease.

Availability heuristic in diagnostic Decision-Making

The availability heuristic describes the tendency to judge the likelihood of an event based on how easily examples come to mind. In clinical practice, this means doctors are more likely to diagnose conditions they’ve seen recently or that are particularly memorable. Common conditions become the default explanation for symptoms, while rarer presentations get overlooked. This bias helps explain why conditions like fibromyalgia, chronic fatigue syndrome, and functional neurological disorders often take years to diagnose—they’re less “available” in the average clinician’s immediate memory compared to more frequently encountered conditions. When a doctor has seen several anxiety patients that week, the next person presenting with palpitations and breathlessness is more likely to receive the same diagnosis, even if an underlying cardiac condition is actually responsible.

Confirmation bias during symptom evaluation

Confirmation bias leads clinicians to seek out information that supports their initial hypothesis whilst unconsciously downplaying or ignoring contradictory evidence. Once a working diagnosis is formed—often within the first few minutes of a consultation—subsequent questioning may focus on confirming this impression rather than testing it. This bias becomes particularly problematic when combined with time pressures. A GP working through a packed surgery may latch onto the most obvious explanation for symptoms and then selectively attend to information that supports this conclusion. Patients often report feeling that their additional symptoms were dismissed or that certain aspects of their history were glossed over, which frequently reflects confirmation bias at work.

Normalcy bias in patient Self-Reporting

Whilst much attention focuses on clinician biases, patients themselves can fall victim to normalcy bias—the tendency to underestimate the severity of symptoms or to believe that unusual experiences will return to normal without intervention. This bias leads people to delay seeking help, to minimise symptoms when they do consult a doctor, and to accept dismissive explan

ations without challenge. In many cultures, we are taught not to “make a fuss” or to assume that feeling unwell is just part of being busy, stressed, or pregnant. As a result, individuals may delay re-consulting when symptoms worsen or new red flags appear, reinforcing the clinician’s original impression that nothing serious is going on. When early-stage symptoms of conditions like cancer, autoimmune disease, or heart disease are normalised in this way, crucial diagnostic windows can be missed before the full clinical picture becomes obvious.

Normalcy bias can be particularly strong in groups who have repeatedly been told that their symptoms are “just anxiety,” “just hormones,” or “just part of getting older.” Over time, you may start to doubt your own experience and under-report what is actually happening. Recognising this bias in yourself—asking, “Am I minimising this because I don’t want it to be serious?”—can be a powerful first step in seeking timely reassessment when symptoms persist, evolve, or interfere with daily life.

Diagnostic overshadowing in comorbid patient populations

Diagnostic overshadowing occurs when an existing diagnosis dominates clinical thinking to such an extent that new or changing symptoms are automatically attributed to that known condition. This is especially common in people with mental health diagnoses, chronic illnesses, or complex medication regimens. While comorbidities do increase the likelihood of symptoms being related, assuming this is always the case can mean that early-stage symptoms of a different, potentially serious disease are missed.

For many patients, diagnostic overshadowing feels like their health record is speaking louder than they are. You might attend an appointment with new pain, unexplained fatigue, or neurological changes, only to be told it’s “just your depression,” “just your fibromyalgia,” or “just a side effect” without thorough investigation. Over time, this pattern can erode trust and make individuals reluctant to report new concerns, reinforcing delays in recognising genuine red-flag symptoms.

Psychiatric diagnosis masking physical symptoms

People with existing psychiatric diagnoses, such as anxiety, depression, bipolar disorder, or PTSD, are particularly vulnerable to having physical symptoms dismissed or reframed as purely psychological. Because conditions like panic disorder or generalised anxiety can mimic heart palpitations, chest pain, breathlessness, and gastrointestinal upset, clinicians may default to mental health explanations when similar complaints appear. If someone has a documented history of anxiety, it can become the “go-to” explanation for almost any vague early-stage symptom.

However, research increasingly shows that mental and physical health are deeply intertwined and that having a psychiatric diagnosis does not protect you from developing additional conditions—if anything, it may increase your risk. A person with an anxiety disorder can still have a heart attack, a stroke, or cancer; yet stories abound of patients whose cardiac symptoms, autoimmune flares, or endocrine problems were repeatedly labelled as “just anxiety” until a crisis forced further investigation. One practical way to reduce this risk is for clinicians to ask, “What feels different about these symptoms compared with your usual anxiety?” and to treat any change in pattern, intensity, or triggers as a cue for more thorough assessment.

Chronic condition attribution errors

Attribution errors also occur frequently in people with long-term health conditions such as diabetes, multiple sclerosis, IBS, chronic fatigue syndrome, or rheumatoid arthritis. When you live with a chronic illness, it is easy—for both you and your clinician—to file every new issue under the existing label. Joint pain in someone with rheumatoid arthritis might be presumed to be “the arthritis acting up,” even when the pattern or location has changed. Persistent bloating and weight loss in someone with IBS may be assumed to be a flare, overlooking the possibility of coeliac disease, inflammatory bowel disease, or even bowel cancer.

This tendency to blame the “usual suspect” can delay recognition of new diseases that share overlapping symptoms. It is similar to assuming that a recurring software bug must always have the same cause, even when the code has changed. For patients with chronic conditions, it can be helpful to keep a simple symptom log that distinguishes between “typical” and “atypical” experiences, noting when something feels qualitatively different or more intense. Sharing these details can help your clinician see beyond the familiar diagnosis and consider whether new investigations are warranted.

Polypharmacy confounding symptom recognition

Polypharmacy—taking multiple medications at the same time—is increasingly common, particularly among older adults and those with complex health needs. While many drugs are essential, they also carry side effects that can look very similar to early-stage disease symptoms: dizziness, fatigue, nausea, palpitations, mood changes, and cognitive difficulties, to name a few. When new symptoms emerge, both patients and clinicians may assume they are “just a side effect,” rather than exploring the possibility of an additional underlying problem.

This can create a diagnostic fog where genuine warning signs are obscured by a long list of potential medication reactions. Adjusting or switching a drug may temporarily change how you feel, but if the root cause is an undiagnosed condition, the problem can quietly progress. One helpful approach is for clinicians to review not only the medication list but also the timeline: did the symptom precede the new drug, or persist despite dose changes? For patients on several medicines, bringing an updated list to each appointment and asking, “Which of these symptoms are clearly explained by my medication, and which aren’t?” can encourage more nuanced thinking.

Time constraints and clinical throughput pressures

Modern healthcare systems operate under intense time and workload pressures. In many primary care settings, clinicians may have 10–15 minutes—or less—to assess complex presentations, review histories, examine patients, and make management decisions. Under these conditions, cognitive shortcuts become more tempting, and subtle or early-stage symptoms are more likely to be deprioritised. When you are the fifth patient that morning with fatigue or chest discomfort, there is a natural pull toward the quickest, most familiar explanation.

Short appointment times can also limit how much of your story you are able to share. Nuances such as “this is a new kind of pain,” “it only happens at night,” or “it is getting progressively worse” may never be voiced if you feel rushed or interrupted. Studies on medically unexplained symptoms show that patients often need a little extra time to articulate experiences that don’t fit simple categories, yet this is precisely what busy clinics struggle to provide. While systemic change is needed, there are practical steps you can take: preparing a brief written summary of your main symptoms, their onset, and what worries you most can help make the most of limited consultation time and reduce the risk that key details are sidelined.

Atypical disease presentations across demographics

Early-stage symptoms are often dismissed because they don’t match the “textbook” picture of disease that many of us carry in our minds. These textbooks, however, have historically been based on a narrow subset of the population—typically middle-aged white men. As a result, women, younger patients, older adults, and people from diverse ethnic backgrounds may present differently, and their atypical symptoms can be overlooked or reinterpreted as benign. Understanding how age, gender, and ethnicity shape disease expression is crucial for recognising when something that looks “mild” may actually be an early sign of serious illness.

We see this clearly in conditions like heart attack, autoimmune disease, and cancer in pregnancy, where early clues can look very different depending on who is sitting in front of the clinician. If both patients and professionals are only familiar with the classic presentation, anyone who falls outside that pattern is more likely to be told that their symptoms are non-specific, stress-related, or not urgent.

Age-related symptom variation in myocardial infarction

Myocardial infarction (heart attack) is often portrayed as sudden, crushing chest pain radiating down the left arm in an older man. While this can be accurate, many younger patients and older adults present with much subtler, early-stage symptoms. In younger people, early signs may include unusual fatigue, shortness of breath on exertion, or intermittent chest discomfort that comes and goes. In older adults, symptoms may be vague—such as confusion, weakness, or a general sense of being unwell—rather than dramatic chest pain.

Because these presentations don’t match the stereotypical image, they are more likely to be misdiagnosed as anxiety, indigestion, viral illness, or simply “getting older.” Women in particular may describe a tight, heavy, or burning sensation rather than sharp pain, and may prioritise caring responsibilities over seeking urgent help. Recognising that “mild” or intermittent chest symptoms, breathlessness, or unexplained exhaustion can be early warning signs—especially in the presence of risk factors like high blood pressure, diabetes, or family history—may prompt earlier investigation and lifesaving treatment.

Gender-specific manifestations in autoimmune disorders

Autoimmune conditions, including lupus, rheumatoid arthritis, and multiple sclerosis, disproportionately affect women and often evolve gradually, with early-stage symptoms that are easy to dismiss. Fatigue, joint stiffness, rashes, low-grade fevers, hair loss, or brain fog may be chalked up to stress, parenting demands, or hormonal changes, particularly when blood tests are initially inconclusive. Because these illnesses are more prevalent in women, there can be an assumption that symptoms are “just part of being a woman,” rather than possible indicators of systemic disease.

On the other hand, when men develop autoimmune disorders, their symptoms may be perceived as more alarming precisely because they are seen as less typical. This can sometimes lead to faster referral and diagnosis for men than for women with the same condition. To reduce gender bias in autoimmune disease recognition, clinicians are encouraged to look for patterns over time—clusters of symptoms that don’t resolve, worsen cyclically, or affect multiple body systems—rather than assessing each complaint in isolation. For patients, keeping a symptom diary that spans several months can highlight these patterns and support a more holistic discussion during appointments.

Ethnic differences in pain expression and reporting

Cultural background and ethnicity significantly influence how people experience, interpret, and communicate pain. Some cultures encourage stoicism and under-reporting of distress, while others may use more expressive language or body gestures to convey discomfort. Clinicians who are unfamiliar with these variations may unintentionally misjudge the severity of symptoms—either downplaying them in patients who appear calm or dismissing them in those perceived as “overreacting.” This is particularly problematic for early-stage symptoms of conditions like sickle cell disease, endometriosis, or cancer, where pain may be one of the first warning signs.

Research also shows that people from racial and ethnic minority groups are more likely to have their pain undertreated and their symptoms minimised. Assumptions about “pain tolerance,” stereotypes about drug-seeking behaviour, and unconscious bias can all play a role. When individuals sense that their discomfort is not believed, they may stop raising concerns until the problem becomes unbearable. For patients from minority backgrounds, bringing a trusted advocate to appointments, asking for clarification in plain language, and explicitly stating how pain impacts daily activities can help counteract some of these biases, although systemic change is still urgently needed.

Healthcare accessibility barriers and delayed presentation

Even before a symptom can be dismissed by a clinician, many people face significant barriers to accessing care in the first place. Long waiting times, limited appointment availability, transportation challenges, childcare responsibilities, and fears about cost can all delay that initial consultation. For those working multiple jobs, living in rural areas, or navigating unstable housing, taking time off to see a doctor may simply not feel feasible unless symptoms become severe.

These accessibility barriers are compounded by previous negative experiences with healthcare, including discrimination, dismissal, or medical gaslighting. If you have already been told that your pain or fatigue “isn’t serious” or “is just in your head,” you may hesitate to go back when symptoms change or worsen. Over time, this can result in a pattern where people only present when conditions are advanced—cancer that has spread, heart disease that has already caused damage, or autoimmune disease that has significantly impaired function. Improving access is not just about more appointments; it also involves creating environments where people feel safe, heard, and respected when they do seek help.

Medical gaslighting and patient-clinician communication breakdown

Medical gaslighting—when a patient’s symptoms are minimised, dismissed, or attributed to psychological causes without adequate investigation—represents one of the most damaging forms of symptom invalidation. While most clinicians do not intend to cause harm, the impact on patients can be profound: self-doubt, shame, mistrust of healthcare, and even trauma responses. Large reviews of patients with conditions like fibromyalgia, long COVID, endometriosis, and functional neurological disorders show that repeated invalidation can lead individuals to avoid medical care altogether, even when new, unrelated issues arise.

Communication breakdowns often sit at the heart of medical gaslighting. When clinicians feel uncertain, constrained by time, or under pressure to reach a quick conclusion, they may reassure too quickly (“it’s probably nothing serious”) or default to anxiety as an explanation. Patients, for their part, may arrive already anxious, armed with online research, or struggling to articulate complex, fluctuating symptoms. Without conscious effort on both sides to listen, clarify, and collaborate, early-stage symptoms can be brushed aside until they become impossible to ignore.

Gender disparities in pain validation

Gender plays a significant role in whose pain is believed and how it is treated. Studies have consistently shown that women are more likely than men to have their pain attributed to emotional or psychological factors, to be prescribed sedatives rather than adequate pain relief, and to experience longer delays to diagnosis for conditions such as heart disease, autoimmune disorders, and endometriosis. When women report severe or persistent symptoms, they may be labelled as “anxious,” “hormonal,” or “overly sensitive,” especially if standard tests initially appear normal.

These gender disparities are even more pronounced for women from racial or ethnic minority groups, who often face intersecting biases. Over time, repeated invalidation can lead women to downplay or under-report symptoms in order not to appear “dramatic,” which in turn further delays recognition of serious illness. Challenging this pattern requires both structural change and individual strategies: clinicians can consciously ask themselves, “Would I respond the same way if a man reported this level of pain?” while women can feel empowered to say, “I understand the tests are normal, but my symptoms are not. What else can we explore?”

Socioeconomic status impact on clinical credibility

Socioeconomic status can also influence how seriously symptoms are taken. Patients from lower-income backgrounds, those who rely on public insurance, or those who appear less familiar with medical terminology may be perceived—consciously or unconsciously—as less credible historians. Time pressures may further compound this, with assumptions that certain complaints are linked to lifestyle factors rather than underlying disease. A person working a physically demanding job who reports chronic pain or exhaustion, for instance, may be told to “rest more” rather than being evaluated for anaemia, thyroid issues, or cardiac problems.

Conversely, patients who are articulate, well-resourced, or accompanied by a confident advocate may find their concerns explored more thoroughly. This imbalance means that early-stage symptoms in disadvantaged groups are at higher risk of being dismissed or inadequately investigated. To counter this, some clinicians are adopting more structured approaches to history-taking that prioritise symptom patterns and red flags over subjective impressions. For patients, preparing key points in advance and clearly explaining how symptoms affect your ability to work or care for others can help communicate urgency, regardless of background.

Language barriers in symptom description

Language barriers present another significant challenge in recognising and validating early-stage symptoms. When patients and clinicians do not share a common first language—or when complex medical concepts must be conveyed through limited vocabulary—important nuances can be lost. Words like “pressure,” “tightness,” “burning,” or “stabbing” may not translate directly, yet these distinctions can be critical in differentiating benign discomfort from something more serious, such as a heart attack or pulmonary embolism.

Relying on family members, including children, to interpret can introduce further distortion, as some details may be filtered or softened to avoid worry. In such scenarios, clinicians may underestimate the severity of what is being described, and patients may leave without fully understanding the plan or when to return. Using professional interpreters wherever possible, allowing extra time for clarification, and encouraging patients to repeat back their understanding of the assessment can all help bridge this gap. If English is not your first language, it can be helpful to write down key symptom words in advance or bring translated notes to ensure your main concerns are clearly communicated.